×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
戻る Agenda
S35 : Incorporate Patient's ‘ Voice ’ into Clinical Trials with dBM
Session Chair(s)
Naoto Awaji, MSc
Dept. Head of Biometrics Dept.
CHUGAI Pharmaceutical Co., Ltd., Japan
Speaker(s)
Value and Efforts of Digital Biomarkers Utilization in Drug Development
NORIHIRO KAWABATA
JPMA / Chugai Pharmaceutical Co., Ltd., Japan
TF-1 Leader,Drug Evaluation Committee/Head of Specialty Clinical Development Dep
Shinichi Tokuno
The University of Tokyo, Japan
Specially Appointed Professor, Department of Bioengineering,
Sleep dBM – Possibilities and Challenges in Research
Thomas Svensson, MD, PhD
Graduate School of Health Innovation, Kanagawa University of Human Services, Japan
Lecturer
Yoshihiko Furusawa, MD, PhD
Takeda Pharmaceutical Company Limited, Japan
Head of Rare Diseases, Medical Franchise, Japan Medical Office
Kuniko Shoji
Kanagawa University of Human Services, Japan
Vice-Dean, School of Health Innovation